Regulation of Apoptosis by Integrin
Regulation of Apoptosis by Integrin
批准号:
6989472
负责人:
ERKKI RUOSLAHTI
金额:
$20.5万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-22 至 2009-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
One of the most important cellular functions of integrin-mediated cell adhesion to extracellular matrix (ECM) is to promote cell survival by mediating anti-apoptotic signals from ECM to cells. Most types of cells depend on ECM attachment for survival; if denied it, they undergo apoptosis (anoikis). Malignant cells are less dependent on integrin-mediated survival signals than normal cells. A pathway activated by some, but not all, integrins up-regulates the anti-apoptotic protein Bcl-2. In screening for cDNAs that regulate this pathway, we isolated a eDNA for a novel protein, which we have named Bit1. Bit1 is a mitochondrial protein which, when released into the cytoplasm, induces apoptosis. Yeast two-hybrid screening and biochemical data
revealed an interaction between Bit1 and the transcriptional regulator protein Amino-terminal Enhancer of Split (AES). Forced expression of AES also causes apoptosis. The degree of apoptosis correlates with the level of Bit1-AES complexes in the cytoplasm, suggesting that the complex is the pro-apoptotic factor. Transfection with Bcl-2, Bcl-xL, various caspase inhibitors, or activated PI3-K, Akt or H-Ras, does not block apoptosis induced by AES or cytoplasmic Bit1. Plating cells onto fibronectin is the only treatment identified so far that counteracts the apoptosis-inducing effect of Bit1 and AES. The use of alternative adhesion surfaces
and antibody inhibition experiments suggests that the anti-apoptotic effect of Bit1/AES is regulated by specific integrins. The Bit1/AES pathway may be, at least in part, responsible for the anti-apoptotic effect of integrin-mediated cell adhesion. This application proposes experiments to establish the integrin-regulation of the Bit1/AES pathway and to identify the subset of integrins that regulate it, The integrin regulation studies will focus on the formation of the Bit1/AES complex, the presumed pro-apoptotic factor. A crystallographic study on the complex is also proposed. Finally, we will analyze the in vivo function of Bit1 in normal
physiology and in tumorigenesis by using a conditional Bit1 gene knockout, which is already at hand. The results of these studies may delineate a signaling pathway that is of fundamental importance in the anchorage dependence of normal cells. Cells that become malignant may bypass this pathway in becoming anchorage independent and metastatic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Molecular Signatures in Alzheimer's Disease
-
批准号:9317757
-
项目类别:
-
资助金额:$29.25万
-
财政年份:2017
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
A nanosystem for tumor treatment and imaging
-
批准号:9037631
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2014
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
A nanosystem for tumor treatment and imaging
-
批准号:8693780
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2014
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
High-throughput screen to identify modulators of CendR-mediated cellular uptake
-
批准号:8416337
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2012
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
High-throughput screen to identify modulators of CendR-mediated cellular uptake
-
批准号:8262597
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2012
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8624663
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8266011
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8815170
-
项目类别:
-
资助金额:$40.46万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8446448
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Tumor Penetrating Peptides for Cancer Targeting
-
批准号:8085532
-
项目类别:
-
资助金额:$39.63万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Injury-targeted decorin for systemic anti-fibrotic treatment
-
批准号:8199150
-
项目类别:
-
资助金额:$22.04万
-
财政年份:2011
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Molecular Specialization of Tumor Lymphatics
-
批准号:7101746
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Molecular Specialization of Tumor Lymphatics
-
批准号:7417952
-
项目类别:
-
资助金额:$17.13万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Molecular Specialization of Tumor Lymphatics
-
批准号:7231979
-
项目类别:
-
资助金额:$17.13万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Molecular Specialization of Tumor Lymphatics
-
批准号:6953006
-
项目类别:
-
资助金额:$18.07万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
HOMING PEPTIDES FOR THE VASCULATURE IN PROSTATE
-
批准号:6958532
-
项目类别:
-
资助金额:$28.34万
-
财政年份:2005
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrins
-
批准号:6866389
-
项目类别:
-
资助金额:$28.65万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrins
-
批准号:6772235
-
项目类别:
-
资助金额:$39.16万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrins
-
批准号:7197296
-
项目类别:
-
资助金额:$27.17万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
Regulation of Apoptosis by Integrins
-
批准号:7030256
-
项目类别:
-
资助金额:$27.98万
-
财政年份:2004
-
负责人:ERKKI RUOSLAHTI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: